LILA:NASDAQLiberty Latin America Ltd. Analysis
Data as of 2026-08-23 - not real-time
$8.47
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Liberty Latin America Ltd. trades at $8.47, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. The last 30 days have gained 16.2%. With RSI at 59.4 the momentum picture is neutral, alongside a bearish MACD signal. Price has been bracketed by support at $7.59 and resistance at $8.90.
On valuation the read is undervalued — earnings multiple of 13.0 versus a 16.1 sector average, below the peer group. The average analyst target implies 30.7% above today's level.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 39.2%, a beta of 0.20 and a maximum drawdown of 22.9%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
This one splits by horizon — buy in the near term, hold further out, at 3/10 long-term conviction.
On valuation the read is undervalued — earnings multiple of 13.0 versus a 16.1 sector average, below the peer group. The average analyst target implies 30.7% above today's level.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 39.2%, a beta of 0.20 and a maximum drawdown of 22.9%, position sizing matters here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
This one splits by horizon — buy in the near term, hold further out, at 3/10 long-term conviction.
Top Market Events
Liberty Latin America reports 3% rebased OIBDA growth and unveils a $250 million AI-driven IT transformation deal with...DENVER, Colorado, July 27, 2026--Liberty Latin America Ltd.The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting...
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 5.92
- MACD momentum is negative
Medium Term
1–3 yearsPositive
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 13.0 versus sector average of 16.1
- Trading above the 200-day average of 5.92
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 13.0 versus sector average of 16.1
- Negative profit margin of -2.2%
- Analyst targets imply +30.7% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth1.50%
Profit Margin-2.20%
P/E Ratio13.0
ROE-3.72%
ROA1.28%
Debt/Equity905.53
P/B Ratio3.2
Op. Cash Flow$899.1M
Free Cash Flow$431.2M
Industry P/E16.1
Technical Analysis
TrendBullish
RSI59.4
Support$7.59
Resistance$8.90
MA 20$8.40
MA 50$7.48
MA 200$5.92
MACDBearish
VolumeDecreasing
Fear & Greed Index94.41
Valuation
Target Price$11.07
Upside/Downside30.66%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.20
Volatility39.23%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.